Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 3
1994 1
1995 1
1996 2
1997 3
1998 3
1999 4
2000 6
2001 3
2002 7
2003 4
2004 2
2005 2
2006 1
2008 2
2009 3
2010 1
2011 2
2012 3
2013 3
2014 1
2015 2
2016 4
2017 6
2018 6
2019 7
2020 7
2021 7
2022 11
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
On autonomy and participation in rehabilitation.
Cardol M, De Jong BA, Ward CD. Cardol M, et al. Among authors: de jong ba. Disabil Rehabil. 2002 Dec 15;24(18):970-4; discussion 975-1004. doi: 10.1080/09638280210151996. Disabil Rehabil. 2002. PMID: 12528676 Review.
Shared decision-making in patients with multiple sclerosis.
Ubbink DT, Damman OC, de Jong BA. Ubbink DT, et al. Among authors: de jong ba. Front Neurol. 2022 Nov 11;13:1063904. doi: 10.3389/fneur.2022.1063904. eCollection 2022. Front Neurol. 2022. PMID: 36438979 Free PMC article.
Recent advances in rehabilitation.
Wade DT, de Jong BA. Wade DT, et al. Among authors: de jong ba. BMJ. 2000 May 20;320(7246):1385-8. doi: 10.1136/bmj.320.7246.1385. BMJ. 2000. PMID: 10818031 Free PMC article. Review. No abstract available.
Handicap questionnaires: what do they assess?
Cardol M, Brandsma JW, de Groot IJ, van den Bos GA, de Haan RJ, de Jong BA. Cardol M, et al. Among authors: de jong ba. Disabil Rehabil. 1999 Mar;21(3):97-105. doi: 10.1080/096382899297819. Disabil Rehabil. 1999. PMID: 10206348 Review.
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis.
Toorop AA, van Kempen ZLE, Steenhuis M, Nielsen J, Sinnige LGF, van Dijk G, Roosendaal CM, Arnoldus EPJ, Hoitsma E, Lissenberg-Witte BI, de Jong BA, Oosten BWV, Strijbis EMM, Uitdehaag BMJ, Rispens T, Killestein J; NEXT-MS study group. Toorop AA, et al. Among authors: de jong ba. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):482-486. doi: 10.1136/jnnp-2022-330467. Epub 2023 Jan 13. J Neurol Neurosurg Psychiatry. 2023. PMID: 36639226
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.
van Lierop ZY, Toorop AA, van Ballegoij WJ, Olde Dubbelink TB, Strijbis EM, de Jong BA, van Oosten BW, Moraal B, Teunissen CE, Uitdehaag BM, Killestein J, Kempen ZLV. van Lierop ZY, et al. Among authors: de jong ba. Mult Scler. 2022 Jun;28(7):1121-1125. doi: 10.1177/13524585211028833. Epub 2021 Jul 9. Mult Scler. 2022. PMID: 34240631 Free PMC article.
112 results